The Dana-Farber Cancer Institute (DFCI) announced in 2024 during its inaugural October 15th Lobular Breast Cancer Awareness Day celebration in Boston, MA, a new Lobular […]
New Lobular Breast Cancer Research Program at Dana-Farber Cancer Institute Read More »
The $100,000 SNMMI / LBCA Invasive Lobular Carcinoma Imaging Research Fellowship for the 2025 Marsh Shot Fund has been awarded to Randy Yeh, MD, a
Mars Shot Research Fund Awards SNMMI LBCA Invasive Lobular Carcinoma Fellowship Read More »
LBCA’s third Local Advocacy Team (LAT) has launched in the region of the US known as Cascadia, including Washington, Oregon and Idaho and will be
New Local Advocacy Team Launched in Cascadia region of US Read More »
On March 18th Julia K. Levine passed away in Venice, CA after a 12 year battle with metastatic invasive lobular carcinoma (mILC). She leaves a
The Lobular Breast Cancer Alliance Inc. (LBCA) is a national, fully remote independent charitable organization. LBCA focuses on providing education and advocating for more desperately
LBCA Hiring a Development Associate Read More »
Last month, LBCA welcomed Dr. Daniel Stover as the newest member of our critical resource – our Scientific Advisory Board (SAB). An internationally-renowned group of basic,
Dr. Daniel Stover Joins the LBCA Scientific Advisory Board Read More »
In Case You Missed It: A Comprehensive Overview of Lobular Breast Cancer from the leaders of the new Memorial Sloan Kettering lobular breast cancer program
Watch the Comprehensive Overview of Lobular Breast Cancer from Memorial Sloan Kettering Read More »
https://youtu.be/mCQzS86wMSU Hear from Dr. Manisha Bahl about her award winning lobular study proposal, “Improving Detection of ILC on Digital Breast Tomosynthesis and Reducing False-Negative Rates
LBCA is Now on BlueSky! Join us on BlueSky as LBCA continues its efforts to increase awareness of Lobular Breast Cancer on new platforms reaching
LBCA is now on BlueSky! Read More »
There are two important upcoming events hosted by the National Breast Cancer Coalition (NBCC) of which LBCA is a part, and an opportunity to seek
Upcoming National Breast Cancer Coalition Trainings and LBCA Travel Scholarships Read More »
Hear from Dr. Higineo (Jose) Dopeso, Senior Research Scientist with Memorial Sloan Kettering, speaking about his winning ILC research grant application, “Deciphering Molecular Mechanisms and
LBCA was excited to learn recently that Dr. Julie Sutcliffe, professor of internal medicine and biomedical engineering at the University of California, Davis had received
Core to the mission of the LBCA is helping individuals with lobular breast cancer worldwide connect with one another and engage collaboratively to drive awareness
Inviting Advocates to Connect Read More »
In September 2024, Leuven, Belgium was host to the fifth international ILC Symposium. More than 150 researchers, clinicians and individuals who have had or are
My name is Karen and I relocated to Honolulu, HI from Seattle, WA in July 2023 to work with a local health system as its
My ILC Story: Karen Shares her Story with Lobular Breast Cancer Read More »
Lobular Breast Cancer Alliance Inc. (LBCA) is a Delaware nonprofit corporation that is registered as a 501(c)(3) public charity. Tax ID Number: 86-2260246. Donations to LBCA are tax-deductible. to the fullest extent allowed by applicable law.
© 2024 The Lobular Breast Cancer Alliance Inc. | Privacy Policy | Terms of Use | State Fundraising Notices
Site by SuzanneHarrisonWeb.com
Notifications